Category:Signatures

S

• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 1/Signature 1
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 1/Signature 2
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 2/Signature 1
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 2/Signature 2
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 3/Signature 1
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 4/Signature 1
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 4/Signature 2
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 5/Signature 1
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 6/Signature 1
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 7/Signature 1
• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 7/Signature 2
• Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 1/Signature 1
• Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 1/Signature 2
• Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 2/Signature 1
• Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 2/Signature 2
• Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations/Experiment 1/Signature 1
• Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations/Experiment 1/Signature 2
• Gut microbiome alterations in patients with stage 4 hepatitis C/Experiment 1/Signature 1
• Gut microbiome alterations in patients with stage 4 hepatitis C/Experiment 1/Signature 2
• The lung microbiome in moderate and severe chronic obstructive pulmonary disease/Experiment 1/Signature 1
• The lung microbiome in moderate and severe chronic obstructive pulmonary disease/Experiment 1/Signature 2
• The lung microbiome in moderate and severe chronic obstructive pulmonary disease/Experiment 2/Signature 1
• Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease/Experiment 1/Signature 1
• Pyrosequencing study of fecal microflora of autistic and control children/Experiment 1/Signature 1
• Pyrosequencing study of fecal microflora of autistic and control children/Experiment 1/Signature 2
• Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults/Experiment 1/Signature 1
• Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults/Experiment 1/Signature 2
• A comprehensive analysis of breast cancer microbiota and host gene expression/Experiment 1/Signature 1
• A comprehensive analysis of breast cancer microbiota and host gene expression/Experiment 1/Signature 2
• Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1/Signature 1
• Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 2/Signature 1
• Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1/Signature 1
• Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 1/Signature 1
• Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 2/Signature 1
• Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 3/Signature 1
• Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 4/Signature 1
• The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 1/Signature 1
• The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 1/Signature 2
• The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 2/Signature 1
• The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 2/Signature 2
• The tongue microbiome in healthy subjects and patients with intra-oral halitosis/Experiment 1/Signature 1
• The tongue microbiome in healthy subjects and patients with intra-oral halitosis/Experiment 1/Signature 2
• The Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study/Experiment 1/Signature 1
• The Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study/Experiment 1/Signature 2
• Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 1/Signature 1
• Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 1/Signature 2
• Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 2/Signature 1
• Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 2/Signature 2
• Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 1/Signature 1
• Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 1/Signature 2
• Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 2/Signature 1
• Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 2/Signature 2
• High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 1/Signature 1
• High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 1/Signature 2
• High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 2/Signature 1
• High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 2/Signature 2
• High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 3/Signature 1
• High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 3/Signature 2
• Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study/Experiment 1/Signature 1
• Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study/Experiment 1/Signature 2
• The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 1/Signature 1
• The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 1/Signature 2
• The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 2/Signature 1
• The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 2/Signature 2
• 16S gut community of the Cameron County Hispanic Cohort/Experiment 1/Signature 1
• 16S gut community of the Cameron County Hispanic Cohort/Experiment 1/Signature 2
• Analysis of Gut Microbiota in Patients with Parkinson's Disease/Experiment 1/Signature 1
• Analysis of Gut Microbiota in Patients with Parkinson's Disease/Experiment 1/Signature 2
• Gut microbiome alterations in Alzheimer's disease/Experiment 1/Signature 1
• Gut microbiome alterations in Alzheimer's disease/Experiment 1/Signature 2
• Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function/Experiment 1/Signature 1
• Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function/Experiment 1/Signature 2
• Microbiome dynamics of human epidermis following skin barrier disruption/Experiment 1/Signature 1
• Microbiome dynamics of human epidermis following skin barrier disruption/Experiment 1/Signature 2
• Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 1/Signature 1
• Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 1/Signature 2
• Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 2/Signature 1
• Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 2/Signature 2
• Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 1/Signature 1
• Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 1/Signature 2
• Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 2/Signature 1
• Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 2/Signature 2
• Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1/Signature 1
• Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1/Signature 2
• Altered fecal microbiota composition in patients with major depressive disorder/Experiment 1/Signature 1
• Altered fecal microbiota composition in patients with major depressive disorder/Experiment 1/Signature 2
• Altered fecal microbiota composition in patients with major depressive disorder/Experiment 2/Signature 1
• Altered fecal microbiota composition in patients with major depressive disorder/Experiment 2/Signature 2
• High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 1/Signature 1
• High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 1/Signature 2
• High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 2/Signature 1
• High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 2/Signature 2
• High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 3/Signature 1
• High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 3/Signature 2
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1/Signature 1
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1/Signature 2
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 2/Signature 1
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 2/Signature 2
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 3/Signature 1
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 3/Signature 2
• Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests/Experiment 1/Signature 1
• Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests/Experiment 1/Signature 2
• Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing/Experiment 1/Signature 1
• Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing/Experiment 1/Signature 2
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 1/Signature 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 1/Signature 2
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 2/Signature 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 3/Signature 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 4/Signature 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 5/Signature 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 6/Signature 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 7/Signature 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 8/Signature 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 9/Signature 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 10/Signature 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 10/Signature 2
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 11/Signature 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 11/Signature 2
• Molecular analysis of oral microflora in patients with primary Sjögren's syndrome by using high-throughput sequencing/Experiment 1/Signature 1
• Molecular analysis of oral microflora in patients with primary Sjögren's syndrome by using high-throughput sequencing/Experiment 1/Signature 2
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 1/Signature 1
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 1/Signature 2
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 2/Signature 1
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 2/Signature 2
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 3/Signature 1
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 3/Signature 2
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 4/Signature 1
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 5/Signature 1
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 5/Signature 2
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 6/Signature 1
• Dysbiosis signature of fecal microbiota in colorectal cancer patients/Experiment 1/Signature 1
• Dysbiosis signature of fecal microbiota in colorectal cancer patients/Experiment 1/Signature 2
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1/Signature 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1/Signature 2
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 2/Signature 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 2/Signature 2
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 3/Signature 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 3/Signature 2
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1/Signature 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1/Signature 2
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 2/Signature 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 3/Signature 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 4/Signature 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 4/Signature 2
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 5/Signature 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 6/Signature 1
• Gut microbiome in ADHD and its relation to neural reward anticipation/Experiment 1/Signature 1
• Gut microbiome in ADHD and its relation to neural reward anticipation/Experiment 1/Signature 2
• Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 1/Signature 1
• Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 1/Signature 2
• Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 2/Signature 1
• Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 2/Signature 2
• Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function/Experiment 1/Signature 1
• Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function/Experiment 1/Signature 2
• Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease/Experiment 1/Signature 1
• Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease/Experiment 1/Signature 2
• Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease/Experiment 2/Signature 1
• Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease/Experiment 2/Signature 2
• Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations/Experiment 1/Signature 1
• Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations/Experiment 1/Signature 2
• An intermittent hypercaloric diet alters gut microbiota, prefrontal cortical gene expression and social behaviours in rats/Experiment 1/Signature 1
• Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study/Experiment 1/Signature 1
• Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study/Experiment 1/Signature 2
• Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study/Experiment 2/Signature 1
• Diet, physical activity and screen time but not body mass index are associated with the gut microbiome of a diverse cohort of college students living in university housing: a cross-sectional study/Experiment 1/Signature 1
• Diet, physical activity and screen time but not body mass index are associated with the gut microbiome of a diverse cohort of college students living in university housing: a cross-sectional study/Experiment 1/Signature 2
• Diet, physical activity and screen time but not body mass index are associated with the gut microbiome of a diverse cohort of college students living in university housing: a cross-sectional study/Experiment 2/Signature 1
• Diet, physical activity and screen time but not body mass index are associated with the gut microbiome of a diverse cohort of college students living in university housing: a cross-sectional study/Experiment 2/Signature 2
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 1/Signature 1
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 1/Signature 2
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 2/Signature 1
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 2/Signature 2
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 3/Signature 1
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 3/Signature 2
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 4/Signature 1
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 5/Signature 1
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 6/Signature 1
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 6/Signature 2
• Characterization of the salivary microbiome in people with obesity/Experiment 1/Signature 1
• Characterization of the salivary microbiome in people with obesity/Experiment 1/Signature 2
• Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers/Experiment 1/Signature 1
• Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers/Experiment 1/Signature 2
• Gut microbiota in patients after surgical treatment for colorectal cancer/Experiment 1/Signature 1
• Gut microbiota in patients after surgical treatment for colorectal cancer/Experiment 1/Signature 2
• Gut microbiota in patients after surgical treatment for colorectal cancer/Experiment 2/Signature 1
• Gut microbiota in patients after surgical treatment for colorectal cancer/Experiment 2/Signature 2
• Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing/Experiment 1/Signature 1
• Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing/Experiment 1/Signature 2
• Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing/Experiment 2/Signature 1
• Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing/Experiment 2/Signature 2
• Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)/Experiment 1/Signature 1
• Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid/Experiment 1/Signature 1
• Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid/Experiment 1/Signature 2
• Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid/Experiment 2/Signature 1
• Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid/Experiment 2/Signature 2
• Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse/Experiment 1/Signature 1
• Diversified microbiota of meconium is affected by maternal diabetes status/Experiment 1/Signature 1
• Diversified microbiota of meconium is affected by maternal diabetes status/Experiment 1/Signature 2
• Diversified microbiota of meconium is affected by maternal diabetes status/Experiment 2/Signature 1
• Diversified microbiota of meconium is affected by maternal diabetes status/Experiment 3/Signature 1